| IV-76 Hidefumi Kasai Tumor Response Index (TRI): model-based prediction of tumor response and survival in metastatic colorectal cancer patients treated by mFOLFOX6 with bevacizumab Thursday 15:25-16:50 |
| IV-76 Hidefumi Kasai Tumor Response Index (TRI): model-based prediction of tumor response and survival in metastatic colorectal cancer patients treated by mFOLFOX6 with bevacizumab Thursday 15:25-16:50 |